Skip to main navigation Skip to search Skip to main content

Heparin Resistance in Cardiac Surgery with Cardiopulmonary Bypass: Mechanisms, Clinical Implications, and Evidence-Based Management

  • Karina E. Rivera Jimenez
  • , Yahaira M. Mamani Ticona
  • , Giancarlo Gutierrez-Chavez
  • , Cristian O. Astudillo
  • , Edisson Calle
  • , Giancarlo A. Torres Heredia
  • , Dario S. Lopez Delgado
  • , Oriana Rivera-Lozada
  • , Joshuan J. Barboza

Research output: Contribution to journalReview articlepeer-review

Original languageAmerican English
Article number2088
Number of pages20
JournalMedicina (Lithuania)
Volume61
Issue number12
DOIs
StateIndexed - 23 Nov 2025
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Activated clotting time
  • Antithrombin
  • Argatroban
  • Bivalirudin
  • Cardiopulmonary bypass
  • Heparin resistance
  • Unfractionated heparin

Fingerprint

Dive into the research topics of 'Heparin Resistance in Cardiac Surgery with Cardiopulmonary Bypass: Mechanisms, Clinical Implications, and Evidence-Based Management'. Together they form a unique fingerprint.

Cite this